Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine

✍ Scribed by Grob, J.- J.; Amonkar, M. M.; Martin-Algarra, S.; Demidov, L. V.; Goodman, V.; Grotzinger, K.; Haney, P.; Kampgen, E.; Karaszewska, B.; Mauch, C.; Miller, W. H.; Millward, M.; Mirakhur, B.; Rutkowski, P.; Chiarion-Sileni, V.; Swann, S.; Hauschild, A.

• Book ID: 125481358
• Publisher: Oxford University Press
• Year: 2014
• Tongue: English
• Weight: 223 KB
• Volume: 25
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mdu154